Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT00499915Not ApplicableCompleted

NICU Asthma Education and Secondhand Smoke Reduction Study

Role: collaborator

NCT01175369Not ApplicableCompleted

School-based Asthma Therapy: Stage 2 Effectiveness Study

Role: collaborator

NCT00156494Completed

Attitudes About Smoking: A Telephone Survey

Role: collaborator

NCT00156468Not ApplicableCompleted

Office-Based Asthma Screening Intervention

Role: collaborator

NCT00156507Not ApplicableCompleted

Improving Asthma Care for Very Low Birth Weight Infants

Role: collaborator

NCT00156481Completed

A Qualitative Study About Smoking Practices

Role: collaborator

All 6 trials loaded